TY - JOUR
T1 - Association of body mass index with longitudinal rates of retinal atrophy in multiple sclerosis
AU - Filippatou, Angeliki G.
AU - Lambe, Jeffrey
AU - Sotirchos, Elias S.
AU - Fitzgerald, Kathryn C.
AU - Aston, Andrew
AU - Murphy, Olwen C.
AU - Pellegrini, Nicole
AU - Fioravante, Nicholas
AU - Risher, Hunter
AU - Ogbuokiri, Esther
AU - Kwakyi, Ohemaa
AU - Toliver, Brandon
AU - Davis, Simidele
AU - Luciano, Nicholas
AU - Crainiceanu, Ciprian
AU - Prince, Jerry L.
AU - Mowry, Ellen M.
AU - Calabresi, Peter A.
AU - Saidha, Shiv
N1 - Publisher Copyright:
© The Author(s), 2020.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Background: Studies evaluating associations between body mass index (BMI) and optical coherence tomography (OCT) measures in multiple sclerosis (MS) are lacking. Objective: To assess whether elevated BMI is associated with accelerated retinal atrophy. Methods: In this observational study, 513 MS patients were followed with serial spectral-domain OCT for a median of 4.4 years. Participants were categorized as normal weight (BMI: 18.5–24.9 kg/m2), overweight (BMI: 25–29.9 kg/m2), and obese (BMI: ⩾30 kg/m2). Participants with diabetes mellitus or uncontrolled hypertension and eyes with optic neuritis (ON) ⩽6 months prior to baseline OCT or during follow-up were excluded. Statistical analyses were performed with mixed-effects linear regression. Results: Obese patients (n = 146) exhibited accelerated rates of ganglion cell + inner plexiform layer (GCIPL) atrophy relative to normal weight patients (n = 214; –0.57%/year (95% confidence interval (CI): –0.65% to –0.48%) versus –0.42%/year (95% CI: –0.49% to –0.35%); p = 0.012). GCIPL atrophy rate did not differ between overweight (n = 153) and normal weight patients (–0.47%/year vs –0.42%/year; p = 0.41). Each 1 kg/m2 higher BMI was associated with accelerated GCIPL (–0.011%/year; 95% CI: –0.019% to –0.004%; p = 0.003) atrophy. Multivariable analyses accounting for age, sex, race, MS subtype, and ON history did not alter the above findings. Conclusions: Elevated BMI, in the absence of overt metabolic comorbidities, may be associated with accelerated GCIPL atrophy. Obesity, a modifiable risk factor, may be associated with accelerated neurodegeneration in MS.
AB - Background: Studies evaluating associations between body mass index (BMI) and optical coherence tomography (OCT) measures in multiple sclerosis (MS) are lacking. Objective: To assess whether elevated BMI is associated with accelerated retinal atrophy. Methods: In this observational study, 513 MS patients were followed with serial spectral-domain OCT for a median of 4.4 years. Participants were categorized as normal weight (BMI: 18.5–24.9 kg/m2), overweight (BMI: 25–29.9 kg/m2), and obese (BMI: ⩾30 kg/m2). Participants with diabetes mellitus or uncontrolled hypertension and eyes with optic neuritis (ON) ⩽6 months prior to baseline OCT or during follow-up were excluded. Statistical analyses were performed with mixed-effects linear regression. Results: Obese patients (n = 146) exhibited accelerated rates of ganglion cell + inner plexiform layer (GCIPL) atrophy relative to normal weight patients (n = 214; –0.57%/year (95% confidence interval (CI): –0.65% to –0.48%) versus –0.42%/year (95% CI: –0.49% to –0.35%); p = 0.012). GCIPL atrophy rate did not differ between overweight (n = 153) and normal weight patients (–0.47%/year vs –0.42%/year; p = 0.41). Each 1 kg/m2 higher BMI was associated with accelerated GCIPL (–0.011%/year; 95% CI: –0.019% to –0.004%; p = 0.003) atrophy. Multivariable analyses accounting for age, sex, race, MS subtype, and ON history did not alter the above findings. Conclusions: Elevated BMI, in the absence of overt metabolic comorbidities, may be associated with accelerated GCIPL atrophy. Obesity, a modifiable risk factor, may be associated with accelerated neurodegeneration in MS.
KW - Multiple sclerosis
KW - body mass index
KW - optical coherence tomography
KW - retina
UR - http://www.scopus.com/inward/record.url?scp=85083577036&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083577036&partnerID=8YFLogxK
U2 - 10.1177/1352458519900942
DO - 10.1177/1352458519900942
M3 - Article
C2 - 32297826
AN - SCOPUS:85083577036
SN - 1352-4585
VL - 26
SP - 843
EP - 854
JO - Multiple Sclerosis Journal
JF - Multiple Sclerosis Journal
IS - 7
ER -